03 Profile
Vital Signsby Bridgehead
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Clinician · Rare diseases
Jonathan Ilicki: no photograph is held, so the clinician plate is shown instead.
Clinician
Jonathan Ilicki
Licensed physician from Karolinska Institutet, investment manager in Industrifonden's life science team
1
0
0
Sept 2026Oct 2026Nov 2026to date
1
press citation on 1 topic since 16 Sept 2026 · last quoted 16 Sept 2026
02 Quoted on · 1 of 29 topics
Jonathan Ilicki: key facts
- Kind of voice
- Clinician
- Role
- Licensed physician from Karolinska Institutet, investment manager in Industrifonden's life science team
- Quoted on
- Rare diseases
- Tracked press citations
- 1
- Most recently quoted
- 16 Sept 2026
04 On the record · press
What Jonathan Ilicki has said
By outlet · linked articles
- biostock.se1
Where Jonathan Ilicki has been quoted
- 01Industrifonden's Jonathan Ilicki on why orphan drugs follow their own logicbiostock.se · 16 Sept 2026
Verbatim
“I think it's hard to break it down. We know that genetic correlates greatly affect the likelihood of achieving approval for any drug, so that's clearly an important part. But the regulatory framework also plays a role, for example through dialogue with the authorities and their advice along the way, and by reducing the financing risk, which makes the category more attractive to investors.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
- Coventry tot's heartbreaking health battle after 'extremely rare' diagnosiscoventrytelegraph.net
- Takeda launches sleep disorder pill in the US after DEA clearance removes final hurdlereuters.com
- 'Immoral lottery' - Mum's plea after losing daughter to rare diseasethewestmorlandgazette.co.uk
Doctors, nurses, allied health professionals and other registered clinicians quoted in a clinical capacity. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.